JP2025160233A5 - - Google Patents
Info
- Publication number
- JP2025160233A5 JP2025160233A5 JP2025116467A JP2025116467A JP2025160233A5 JP 2025160233 A5 JP2025160233 A5 JP 2025160233A5 JP 2025116467 A JP2025116467 A JP 2025116467A JP 2025116467 A JP2025116467 A JP 2025116467A JP 2025160233 A5 JP2025160233 A5 JP 2025160233A5
- Authority
- JP
- Japan
- Prior art keywords
- ppm
- concentration
- composition according
- deoxycytidine
- ethanol
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962888893P | 2019-08-19 | 2019-08-19 | |
| US62/888,893 | 2019-08-19 | ||
| JP2022510955A JP7769603B2 (ja) | 2019-08-19 | 2020-08-19 | デオキシシチジンの多形形態、それを含む組成物および使用 |
| PCT/US2020/047047 WO2021034962A1 (en) | 2019-08-19 | 2020-08-19 | Polymorphic forms of deoxycytidine, compositions comprising the same and uses |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022510955A Division JP7769603B2 (ja) | 2019-08-19 | 2020-08-19 | デオキシシチジンの多形形態、それを含む組成物および使用 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2025160233A JP2025160233A (ja) | 2025-10-22 |
| JP2025160233A5 true JP2025160233A5 (cg-RX-API-DMAC7.html) | 2026-04-13 |
Family
ID=74647126
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022510955A Active JP7769603B2 (ja) | 2019-08-19 | 2020-08-19 | デオキシシチジンの多形形態、それを含む組成物および使用 |
| JP2025116467A Pending JP2025160233A (ja) | 2019-08-19 | 2025-07-10 | デオキシシチジンの多形形態、それを含む組成物および使用 |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022510955A Active JP7769603B2 (ja) | 2019-08-19 | 2020-08-19 | デオキシシチジンの多形形態、それを含む組成物および使用 |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US11649259B2 (cg-RX-API-DMAC7.html) |
| EP (1) | EP4017502A4 (cg-RX-API-DMAC7.html) |
| JP (2) | JP7769603B2 (cg-RX-API-DMAC7.html) |
| CN (1) | CN114929240B (cg-RX-API-DMAC7.html) |
| AU (1) | AU2020334060B2 (cg-RX-API-DMAC7.html) |
| BR (1) | BR112022002513A2 (cg-RX-API-DMAC7.html) |
| CA (1) | CA3150755A1 (cg-RX-API-DMAC7.html) |
| WO (1) | WO2021034962A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2022204555A1 (en) * | 2021-03-26 | 2022-09-29 | Zogenix Mds, Inc. | Aqueous solutions containing purines and pyrimidines and uses thereof |
| WO2026082601A2 (en) * | 2024-10-15 | 2026-04-23 | UCB Biopharma SRL | Method of purification |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4898936A (en) * | 1984-09-24 | 1990-02-06 | Pcr, Inc. | 2-deoxyuridines and riboside precursors |
| JPS61135597A (ja) * | 1984-12-06 | 1986-06-23 | Takeda Chem Ind Ltd | シチジンおよびデオキシシチジンの製造法 |
| US4900828A (en) * | 1988-05-12 | 1990-02-13 | Hoffmann-Laroche Inc. | Intermediate compounds and an improved procedure for the synthesis of 2',3'-dideoxycytidine |
| JP2002255991A (ja) * | 2000-12-27 | 2002-09-11 | Mitsui Chemicals Inc | 保護化2’−デオキシシチジン誘導体の製造法 |
| JP2002293791A (ja) * | 2001-03-30 | 2002-10-09 | Mitsui Chemicals Inc | 保護化2’−デオキシシチジン誘導体の精製法 |
| CN100424091C (zh) * | 2002-06-05 | 2008-10-08 | 三井化学株式会社 | 保护化2’-脱氧胞苷类的精制法 |
| EP1551838B1 (en) * | 2002-10-16 | 2006-08-09 | Teva Pharmaceutical Industries Ltd. | Method for reducing residual alcohols in crystalline valacyclovir hydrochloride |
| US9669048B2 (en) * | 2012-10-25 | 2017-06-06 | Fresenius Kabi Oncology Limited | Stable pharmaceutical composition of 5-aza-2′-deoxycitidine |
| WO2016205671A1 (en) | 2015-06-17 | 2016-12-22 | The Trustees Of Columbia University In The City Of New York | Deoxynucleoside therapy for diseases caused by unbalanced nucleotide pools including mitochondrial dna depletion syndromes |
| GB2580963C (en) * | 2019-02-01 | 2025-09-03 | Hemispherian As | Cancer therapies |
-
2020
- 2020-08-19 EP EP20854948.5A patent/EP4017502A4/en active Pending
- 2020-08-19 AU AU2020334060A patent/AU2020334060B2/en active Active
- 2020-08-19 BR BR112022002513A patent/BR112022002513A2/pt unknown
- 2020-08-19 US US16/997,727 patent/US11649259B2/en active Active
- 2020-08-19 JP JP2022510955A patent/JP7769603B2/ja active Active
- 2020-08-19 CN CN202080073216.4A patent/CN114929240B/zh active Active
- 2020-08-19 CA CA3150755A patent/CA3150755A1/en active Pending
- 2020-08-19 WO PCT/US2020/047047 patent/WO2021034962A1/en not_active Ceased
-
2025
- 2025-07-10 JP JP2025116467A patent/JP2025160233A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP7253866B1 (ja) | トリアジン誘導体を含有する経口投与する製剤 | |
| US20170022194A1 (en) | Stable crystalline noribogaine salt ansolvates | |
| JP2025531807A (ja) | 細胞傷害性イミダゾ[1,2-a]ピリジン化合物及び治療におけるその使用 | |
| PT100234B (pt) | Novos esteres de alcoois aminados biciclicos e triciclicos, processo para a sua preparacao | |
| CA2744231A1 (en) | Polymorphs of (s)-3-aminomethyl-7-(3-hydroxy-propoxy)-3h-benzo[c][1,2] oxaborol-1-ol | |
| JPH02131425A (ja) | 抗ウイルス剤 | |
| JP2021535111A5 (cg-RX-API-DMAC7.html) | ||
| JP2004528336A (ja) | アジスロマイシン水和物の1,2−プロピレングリコール包接化合物、その製造方法およびそれを含む医薬組成物 | |
| JP2025160233A (ja) | デオキシシチジンの多形形態、それを含む組成物および使用 | |
| JPS6249270B2 (cg-RX-API-DMAC7.html) | ||
| CN109485676A (zh) | 用于抗病毒的新型核苷类逆转录酶抑制剂 | |
| JP2012521417A (ja) | アデフォビルジピボキシルの新規結晶形及びその製造方法 | |
| JPS5823866B2 (ja) | ウレアおよびチオウレア誘導体 | |
| WO2005027856A2 (en) | Inhibitors of anthrax lethal factor | |
| CA3215792A1 (en) | Processes for the synthesis of valbenazine | |
| CA2582778A1 (fr) | Derives de pyridine, leur preparation, leur application en therapeutique | |
| JPH0322394B2 (cg-RX-API-DMAC7.html) | ||
| TWI239327B (en) | Aminohydroxylation of olefins in the presence of acetamide | |
| CN116492363A (zh) | 新的核苷氨基磷酸脂化合物的组合物及其制备方法 | |
| Miller III et al. | The Pharmacological Activities of the Metabolites of N‐[(Trimethylamineboryl)‐Carbonyl]‐L‐Phenylalanine Methyl Ester | |
| US9328061B2 (en) | Simple organic molecules as catalysts for practical and efficient enantioselective synthesis of amines and alcohols | |
| CA2315835C (en) | New crystalline form of 1-methyl-5-p-toluoylpyrrole-2-acetamidoacetic acid guaiacyl ester | |
| JP2024546397A (ja) | 4’-置換ヌクレオシドの結晶、その製造方法、組成物及び使用 | |
| TW202532060A (zh) | 醫藥組成物 | |
| JP2009505945A5 (cg-RX-API-DMAC7.html) |